Introduction
Methods
Study Design and Participants
Statistical Analyses
Results
Group A (N = 322) | Group B (N = 551) | Group C (N = 485) | Overall (N = 1358) | |
---|---|---|---|---|
Age, years | ||||
< 50 | 3 (0.9%) | 4 (0.7%) | 2 (0.4%) | 9 (0.7%) |
50 to < 65 | 68 (21.1%) | 137 (24.9%) | 101 (20.8%) | 306 (22.5%) |
65 to < 80 | 202 (62.7%) | 307 (55.7%) | 276 (56.9%) | 785 (57.8%) |
≥ 80 | 49 (15.2%) | 103 (18.7%) | 106 (21.9%) | 258 (19.0%) |
Mean (SD) | 71.6 (8.4) | 71.7 (8.9) | 73.0 (8.5)* | 72.1 (8.7) |
Geographical region | ||||
North America | 42 (13.0%) | 77 (14.0%) | 72 (14.8%) | 191 (14.1%) |
South America | 84 (26.1%) | 132 (24.0%) | 84 (17.3%) | 300 (22.1%) |
Europe | 196 (60.9%) | 342 (62.1%) | 329 (67.8%) | 867 (63.8%) |
Race | ||||
White | 315 (97.8%) | 531 (96.4%) | 475 (97.9%) | 1321 (97.3%) |
Black or African American | 1 (0.3%) | 14 (2.5%) | 5 (1.0%) | 20 (1.5%) |
Asian | 5 (1.6%) | 2 (0.4%) | 5 (1.0%) | 12 (0.9%) |
Other | 1 (0.3%) | 4 (0.7%) | 0 | 5 (0.4%) |
Mean height, cm (SD)a | 155.8 (7.3) | 155.2 (7.2) | 153.7 (7.2)# | 154.8 (7.3) |
Mean weight, kg (SD) | 66.1 (11.8) | 65.0 (12.2) | 63.8 (11.2)† | 64.8 (11.8) |
Mean body mass index, kg/m2 (SD)b | 27.2 (4.5) | 26.9 (4.8) | 27.0 (4.5) | 27.0 (4.6) |
Mean bone mineral density, g/cm2 (SD) | ||||
Lumbar Spinec | 0.883 (0.147)¥ | 0.849 (0.149) | 0.849 (0.154) | 0.857 (0.151) |
Femoral Neckd | 0.681 (0.105) | 0.671 (0.106) | 0.646 (0.117)# | 0.664 (0.111) |
Total Hipe | 0.757 (0.099) | 0.740 (0.097)‡ | 0.715 (0.130)# | 0.735 (0.112) |
Antecedent of a recent clinical vertebral fragility fracture | 105 (32.6%) | 188 (34.1%) | 202 (41.6%)* | 495 (36.5%) |
Patients with ≥ 1 previous osteoporosis therapy | 215 (66.8%) | 400 (72.6%) | 364 (75.1%)† | 979 (72.1%) |
Patients with recent use of bisphosphonates | 115 (35.7%) | 221 (40.1%) | 197 (40.6%) | 533 (39.2%) |
Patients with ≥ 1 previous glucocorticoid therapy | 22 (6.8%) | 44 (8.0%) | 31 (6.4%) | 97 (7.1%) |
Mean 25-hydroxy-vitamin D concentration, ng/mL (SD)f | 29.9 (18.1) | 31.1 (18.3) | 33.6 (29.8) | 31.7 (23.0) |